Organizations Filed Purposes:
CURES WITHIN REACH IMPROVES PATIENT QUALITY AND LENGTH OF LIFE BY LEVERAGING THE SPEED, SAFETY AND COST-EFFECTIVENESS OF MEDICAL REPURPOSING RESEARCH, DRIVING MORE TREATMENTS TO MORE PATIENTS MORE QUICKLY.
TO HELP PATIENTS BY RAISING FUNDS TO FIND, VET, FINANCE & MANAGE PILOT HUMAN CLINICAL RESEARCH THAT REPURPOSES DRUGS, DEVICES & OTHER PRODUCTS THAT DELIVER FAST,SAFE, & AFFORDABLE TREATMENTS FOR BOTH COMMON & RARE DISORDERS THAT DO NOT HAVE A CURRENT EFFECTIVE TREATMENT.
REPURPOSING RESEARCH:ITS MAIN AREA OF FOCUS, THE ORGANIZATION CATALYZES REPURPOSING RESEARCH OPPORTUNITIES BY FACILITATING RESEARCH FUNDING AMONG REPURPOSING STAKEHOLDERS, AND SOLICITING AND VETTING REPURPOSING RESEARCH. IN FY 2020, 5 NEW REPURPOSING PROJECTS WERE SIGNED (IN RARE DISEASES, ONCOLOGY, NEUROLOGICAL AND OTHER DISEASES), WHILE 4 PROJECTS WERE COMPLETED (IN ONCOLOGY, RARE AND OTHER DISEASES), AND 16 PROJECTS STILL IN PROGRESS - FOR A TOTAL OF 21 ONGOING PROJECTS AS OF 7/31/2020.REGROW PILOT:DURING FY 2020, THE ORGANIZATION FORMALLY LAUNCHED ITS REGROW PILOT. THE PILOT YEAR OF THIS NEW PROGRAM PROVIDES REPURPOSING RESEARCH GRANTS TO CLINICIANS AND RESEARCHERS BASED IN THE DEVELPING WORLD (DEFINED AS LOW AND LOW-MIDDLE INCOME CONTRIES, LMIC'S, PER THE WORLD BANK) TO BUILD CAPACITY FOR RESEARCH FROM WITHIN THE DEVELOPING WORLD AND FIND TREATMENTS FOR THE DEVELOPING WORLD. DURING FY 2020, THE ORGANIZATION LAUNCJED THE FUNDING OPPORTUNITY RFP FOR REGROW, AND IN EARLY FY 2021, FOUR PROJECTS WERE APPROVED FOR FUNDING. CUREACCELERATOR LIVE!:CUREACCELERATOR LIVE! IS THE ORGANIZATION'S UNIQUE PHILANTHROPIC PITCH EVENT THAT BRINGS TOGETHER STAKEHOLDERS FROM PHARMA, BIOTECH, ACADEMIA, MEDICINE, PHILANTHROPY AND PATIENT GROUPS TO SHOWCASE REPURPOSING PROJECTS IN NEED OF FUNDING. CLINICAL RESEARCHERS ARE SELECTED AS FINALISTS THROUGH AN EXTERNALLY VETTED PROCESS AFTER PROPOSAL SUBMISSIONS. FINALISTS PITCH THEIR CLINICAL REPURPOSING TRIALS AT THE EVENT AND ATTENDEES VOTE FOR THE WINNING REPURPOSING CLINICAL TRIAL. THE WINNING PROJECT IS ANNOUNCED AT THE EVENT ALONG WITH A GRANT COMMITMENT FROM THE ORGANIZATION. IN FY 2020, THE ORGANIZATION HELD ONE CUREACCELERATOR LIVE! PITCH EVENT VIRTUALLY, ON RARE DISEASES IN JUNE.
Executives Listed on Filing
Total Salary includes financial earnings, benefits, and all related organization earnings listed on tax filing
| Name | Title | Hours Per Week | Total Salary |
|---|
| Barbara Goodman | PRESIDENT & CEO | 40 | $165,000 |
| Matthew Rich | TREASURER | 1 | $0 |
| Lucy Mancini-Newell | SECRETARY | 1 | $0 |
| Margaret Christie | CHAIR | 2 | $0 |
| Nancy Sullivan | DIRECTOR | 1 | $0 |
| David Styler | DIRECTOR | 1 | $0 |
| Robert Metz | DIRECTOR | 1 | $0 |
| Nicholas Manusos | DIRECTOR | 1 | $0 |
| Elizabeth Downey | DIRECTOR | 1 | $0 |
| Steve Braun | DIRECTOR | 1 | $0 |
| Kristina Allikmets | DIRECTOR | 1 | $0 |
Data for this page was sourced from XML published by IRS (
public 990 form dataset) from:
https://s3.amazonaws.com/irs-form-990/202100299349300620_public.xml